LCD L39529: Intraarticular Knee Injections of Hyaluronan — WPS
Orthopedics
Government source· CMS / MACverify ↗HCPCS Level II code
J7321 — Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
HCPCS Level IIVerified Sep 19, 2026
Medicare payment
—
No national Medicare fee schedule we hold prices J7321 — the Physician Fee Schedule lists it with status indicator E (2026 file). CMS fee schedules ↗
Code definition
Code
J7321
Code system
HCPCS Level II
Full description
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
Policy activity for HCPCS J7321
CLV Intelligence is tracking 2 policy changes that cite HCPCS J7321 most recently on 2026-09-12, drawn from 2 LCD/NCD coverage updates. The changes span Orthopedics.
- LCD/NCD coverage updates
- 2
Counts reflect the source documents CLV has matched to HCPCS J7321 to date; each links to the government publication that is authoritative. Monitored daily from CMS, the Federal Register, and Medicare Administrative Contractor publications.
Recent policy changes matched to J7321
Matched to this code by CLV analysis of each policy. The linked source document is authoritative.
Audit documentation
Building an audit file that includes HCPCS J7321?
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
See audit packs — $349One-time purchase · not a subscription
Get alerts when policy changes affect J7321
Free weekly digest — no subscription required.
Get the free 90-day policy snapshot for your specialty
Free — no account required
See what CLV monitors for your specialty
Get a free 90-day sample snapshot — a PDF of every CMS and MAC policy change we tracked for your specialty and jurisdiction in the last quarter. Delivered instantly.
90-day windowPDF sample reportInstant download
By downloading, you agree to receive related policy update emails. You can unsubscribe at any time. Privacy policy